Use of carvedilol in the treatment of heart failure.
Carvedilol is a multiple action, non-specific, adrenergic beta-blocker, licensed for the treatment of mild, moderate and severe chronic heart failure. This article considers the evidence for using beta-blockers in general, and carvedilol in particular, in the treatment of heart failure. Evidence suggests that carvedilol should be considered as an alternative first-line initiation therapy.
Coats
Andrew
A
Faculty of Medicine, University of Sydney, NSW, 2006, Australia.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002227:Carbazoles / Q000627:therapeutic use*; D002303:Cardiac Output, Low / Q000188:drug therapy*; D000077261:Carvedilol; D002908:Chronic Disease; D006801:Humans; D011412:Propanolamines / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol